BioWorld Science

Oct. 14, 2003

View Archived Issues

CT-3 effective in chronic neuropathic pain

Read More

Bax channel modulators as novel antiapoptotic compounds

Read More

Omega-3 fatty acids and antioxidants improve schizophrenia

Read More

New polyamine is effective and well tolerated in human prostate xenograft models

Read More

Novel VEGFR2 modulators prepared and tested at Pfizer

Read More

Merck KGaA team discovers new integrin inhibitors for thrombosis, cardiovascular disorders, etc.

Read More

New DPP-IV inhibitors covered by Sanofi-Synthelabo patent

Read More

Novel imaging agents with potential in the diagnosis and monitoring of AD patients

Read More

Yeda researchers claim new neurotrophic agents for schizophrenia and cognition deficits

Read More

New topical antiinflammatory agents and their use described by Japan Energy

Read More

Selective MMP-13 inhibitors synthesized by Aventis researchers

Read More

Topical bimosiamose studied in psoriasis and atopic dermatitis

Read More

Genentech product development events

Read More

FDA accepts Erbitux BLA for filing

Read More

Marketing approval sought for rasagiline in Europe

Read More

Nabi accelerates E.U. timeline for StaphVAX

Read More

Estrasorb approved for reduction of vasomotor symptoms in menopausal women

Read More

Approval for prefilled syringe presentation of Ovidrel

Read More

Xoma discontinues development of MLN-2201

Read More

AWD-12-353 exerts strong and long-lasting antiinflammatory effects in asthma and COPD

Read More

Unique class of dopamine D4-selective compounds under study at Schering-Plough and Neurogen

Read More

Posaconazole clinically effective in coccidioidomycosis

Read More

Anidulafungin as safe as fluconazole in esophageal candidiasis

Read More

Characterization of SU-10944, an orally active small-molecule inhibitor of VEGFR-2

Read More